FDA Investigator Nataniel Phillips Sylvain, PhD
Nataniel Phillips Sylvain, PhD has conducted inspections on 9 sites in 1 countries as of 28 Nov 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
28 Nov 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Nataniel Phillips Sylvain, PhD:
Amanda L Fyles,
Andrew "Drew" Haack, PhD,
Andrew K Haack, PhD,
Anissa M Vargas,
Anita Narula, PhD,
Arie C Menachem,
Barbara Janine Breithaupt,
Brian M Janelsins, PhD,
Bryce E Mansfield,
Carrie A Hughes,
CDR Donald Ertel,
Charles Yuanchia Kuo, PhD,
Chava Kimchi Sarfaty, PhD,
Chiaochun J Wang,
Christopher R Czajka,
Colleen F Hoyt,
Crystal Monroy,
David P Vanhouten,
Deborah A Nebenzahl,
Deborah M Trout,
Dennis G Kawabata,
Dennis R Hudson,
Diana M Rand,
George Lunn, PhD,
Gerard Pde Leon,
Gloria J Baca, MS,
Heika R Tait,
Huiquan Wu,
Hung H Do, MS,
James C Henry,
Jeffrey P Raimondi,
Joan Johnson,
Kathryn E King,
Kenneth O Gee, PhD,
Ko U Min,
Linda F Murphy,
Lisa K Capron,
Marijo B Kambere, PhD,
Michael S Araneta,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Nancy E Byerly,
Nicholas L Hunt,
Prabhu P Raju,
Rabia Ballica, PhD,
Randall N Johnson,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Robert D Tollefsen,
Roger F Zabinski,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Sridhar Thumma,
Stephen R Souza,
Teegan Dellibovi Ragheb, PhD,
Thuy T Nguyen, LCDR,
Timothy T Kapsala,
Tracy K Li,
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Vioela J Caze,
Wayne E Seifert,
William J Leonard,
Xing Wang, PhD,
Yideng Liang,
Yuan Chia Kuo,
Zachary A Bogorad,
Zachary L Stamm,
Zhong Li, PhD
Nataniel Phillips Sylvain, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2021 | EIR | AGC Biologics, Inc. - EIR, 2021-03-19 |
August, 2022 | FDA 483 | Lonza Bend Inc. - Form 483, 2022-08-05 |
October, 2020 | FDA 483 | Providence Health and Services Washington Dba Providence Infusion Hospital Services - Form 483, 2020-10-05 |
November, 2021 | EIR | Univar Solutions USA Inc. - EIR, 2021-11-01 |
March, 2021 | FDA 483 | First Pharma Associates LLC dba Riverpoint Pharmacy - Form 483, 2021-03-03 |
May, 2022 | FDA 483 | Omya Inc. - Form 483, 2022-05-27 |
November, 2021 | FDA 483 | Univar Solutions USA Inc. - Form 483, 2021-11-01 |
March, 2021 | FDA 483 Response | AGC Biologics, Inc. - Form 483R, 2021-04-09 |
March, 2020 | FDA 483 | La Vita Compounding Pharmacy, LLC - Form 483, 2020-03-11 |
March, 2021 | FDA 483 | AGC Biologics, Inc. - Form 483, 2021-03-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more